[Translation]
December 29, 2021
To whom it may concern:

Company Name:

Mitsui & Co., Ltd.

Name of Representative:

Kenichi Hori
President and Chief Executive Officer(Securities code: 8031)

Contact:

Masaya Inamuro
General Manager of Investor Relations
Division

Phone:+81-3-3285-7657

Company Name:

MBK Wellness Holdings & CO., LTD.

Name of Representative:

Yoshitaka Oshiba
Representative Director

Contact:

Same as above

Notice Regarding Results of Tender Offer for Shares of
Human Associates Holdings, Inc. (Securities Code: 6575)

MBK Wellness Holdings & CO., LTD. (the "Offeror"), which is a wholly-owned subsidiary of Mitsui &Co., Ltd. ("Mitsui & Co.," and together with the Offeror, the "Offeror Parties") launched on November 16,2021 a tender offer (the "Tender Offer") for shares of the common stock of Human Associates Holdings,
Inc. (the "Target") (listed on the Mothers Market of Tokyo Stock Exchange, Inc. (the "TSE") under
securities code 6575; the "Target's Stock") and the Stock Acquisition Rights of the Target (the term "Stock
Acquisition Rights" and the names of specific series thereof are defined in "(3) Types of securities to bepurchased" under "1. Summary of Tender Offer" below; hereinafter the same). The Tender Offer wascompleted on December 28, 2021, and the Offeror Parties hereby report on the results as follows:11. Summary of Tender Offer(1) Name and location of the Offeror
Name:

MBK Wellness Holdings & CO., LTD.

Location:

2-1, Otemachi 1-chome, Chiyoda-ku, Tokyo(2) Name of the Target
Human Associates Holdings, Inc.

(3) Types of securities to be purchased(I)

Common stock(II) Stock acquisition rights
The stock acquisition rights issued pursuant to the resolution of the Target's board of
directors meeting on March 4, 2016 (the "First Stock Acquisition Rights") (exercise period:from March 12, 2018 through March 4, 2026)(ii) The stock acquisition rights issued pursuant to the resolution of the Target's board of
directors meeting on January 16, 2017 (the "Second Stock Acquisition Rights") (exerciseperiod: from January 20, 2019 through January 16, 2027)(iii) The stock acquisition rights issued pursuant to the resolution of the Target's board of
directors meeting on February 15, 2017 (the "Third Stock Acquisition Rights") (exerciseperiod: from February 23, 2019 through February 15, 2027)(iv) The stock acquisition rights issued pursuant to the resolution of the Target's board of
directors meeting on November 14, 2017 (the "Fourth Stock Acquisition Rights") (exercise
period: from November 23, 2019 through November 14, 2027)(v) The stock acquisition rights issued pursuant to the resolution of the Target's board of
directors meeting on June 27, 2019 (the "Fifth Stock Acquisition Rights") (exercise period:from July 2, 2021 through June 27, 2029)(i)

The First Stock Acquisition Rights, the Second Stock Acquisition Rights, the Third Stock
Acquisition Rights, the Fourth Stock Acquisition Rights, and the Fifth Stock Acquisition Rights
are collectively referred to as the "Stock Acquisition Rights."(4) Number of shares to be purchased

Class of stock

Number of tenderedshares to be purchased

Minimum number ofMaximum number oftendered shares to betendered shares to bepurchased

purchased

Common Stock

3,445,876 shares

2,297,400 shares- sharesTotal

3,445,876 shares

2,297,400 shares- shares(Note 1) If the total number of shares tendered in the Tender Offer (the "Tendered Shares")(including the number of shares underlying the Stock Acquisition Rights; hereinafter the2same) is less than the minimum number of tendered shares to be purchased in the Tender
Offer (2,297,400 shares), the Offeror will purchase none of the Tendered Shares. If thetotal number of the Tendered Shares is no less than the minimum number of tenderedshares to be purchased in the Tender Offer (2,297,400 shares), the Offeror will purchaseall of the Tendered Shares.
(Note 2) Since the maximum number of tendered shares to be purchased is not set in the TenderOffer, the number of tendered shares to be purchased is the Total Number of Shares
Adjusted for Dilutive Shares* (3,445,876 shares), which is the maximum number ofshares that the Offeror may acquire by the Tender Offer.
* "Total Number of Shares Adjusted for Dilutive Shares" refers to the number of sharescalculated by the following formula:
X+Y-Z
X:

The total number of issued shares as of November 15, 2021 as stated in the Target's"Quarterly Securities Report for the Second Quarter of the 33 rd Term" (the "2Q
Securities Report") (3,255,237 shares) (according to the Target, this figure does notinclude the number of shares of the Target's Stock issued upon the exercise of theStock Acquisition Rights during the period from November 1, 2021 to the date offiling of the 2Q Securities Report.)
Y: The number of shares (190,756 shares) underlying the Stock Acquisition Rights
outstanding as of October 31, 2021 (127,878 rights) (according to the Target,comprising 26,960 First Stock Acquisition Rights (number of underlying shares:
53,920 shares), 16,118 Second Stock Acquisition Rights (number of underlying
shares: 32,236 shares), 1,200 Third Stock Acquisition Rights (number of underlyingshares: 2,400 shares), 18,600 Fourth Stock Acquisition Rights (number ofunderlying shares: 37,200 shares), and 65,000 Fifth Stock Acquisition Rights(number of underlying shares: 65,000 shares)) (*X+Y= 3,445,993 shares)
Z: The number of treasury shares owned by the Target as of November 15, 2021 (117shares)(Note 3) Shares less than one unit (excluding the shares less than one unit owned by the Target)
are also subject to the Tender Offer. If a shareholder of the Target exercises the right todemand the purchase of shares less than one unit pursuant to the Companies Act (Act No.
86 of 2005, as amended), the Target may purchase its shares during the period of purchasein the Tender Offer (the "Tender Offer Period") in accordance with statutory procedures.
(Note 4) The treasury shares owned by the Target are not scheduled to be acquired through theTender Offer.
(Note 5) If any of the Stock Acquisition Rights are exercised by the last day of the Tender Offer
Period, the shares of the Target's Stock issued or transferred as a result of such exercise
will also be subject to the Tender Offer.
(5) Period of purchase(I)

Tender offer period as of the submission date of the tender offer registration statement
From November 16, 2021 (Tuesday) through December 28, 2021 (Tuesday) (30 business days)(II) Possibility of extending the above period upon request from the Target
Not applicable.

(6) Price of tender offer
Common stock:

915 yen per share3

First Stock Acquisition Rights:

1 yen per stock acquisition right

Second Stock Acquisition Rights:

1 yen per stock acquisition right

Third Stock Acquisition Rights:

1 yen per stock acquisition right

Fourth Stock Acquisition Rights:

1 yen per stock acquisition rightFifth Stock Acquisition Rights:

1 yen per stock acquisition right

2. Results of the Tender Offer(1) Whether the Tender Offer has been successful
In the Tender Offer, a condition was set that if the total number of the Tendered Shares is less than theminimum number of tendered shares to be purchased (2,297,400 shares), the Offeror will purchasenone of the Tendered Shares. However, the total number of Tendered Shares (3,187,275 shares)
resulted in no less than the minimum number of tendered shares to be purchased in the Tender Offer(2,297,400 shares), and the Offeror will therefore purchase all of the Tendered Shares as stated in thepublic notice on the commencement of the tender offer and the tender offer registration statement.

(2) Date of public notice on the results of the Tender Offer, and the name of the newspaper in which thepublic notice was publishedPursuant to Article 27-13, Paragraph 1 of the Financial Instruments and Exchange Act (Act No. 25 of1948, as amended; the "Act"), on December 29, 2021, the Offeror announced to the press the resultsof the Tender Offer at TSE, by the method prescribed in Article 9-4 of the Order for Enforcement of
the Financial Instruments and Exchange Act (Cabinet Order No. 321 of 1965, as amended) and Article30-2 of the Cabinet Office Ordinance on Disclosure Required for Tender Offer for Share Certificates,etc. by Persons Other Than Issuers (Ordinance of the Ministry of Finance No. 38 of 1990, as amended;the "Cabinet Office Ordinance").

(3) Number of purchased shares
Type of Securities

a. Number of tendered shares after conversion

b. Number of purchased shares after conversion

3,187,275 shares

3,187,275 shares

Share options certificates- shares- shares

Corporate bond certificates withshare options- shares- sharesBeneficiary certificates of sharesin trust()- shares- shares

Depository receipts for shares()- shares- shares3,187,275 shares

3,187,275 shares(-) shares(-) shares

Shares

Total(Total number of dilutive shares)4(4) Shareholding ratio after the Tender Offer
Numberof

votingrightspertaining to the shares held by0

the Offeror before the Tender(Shareholding ratio before the Tender Offer0.00%)

Offer
Numberofvotingrights

pertaining to the shares held by

0special related parties before(Shareholding ratio before the Tender Offer0.00%)

the Tender Offer
Numberofvoting

rightspertaining to the shares held by

31,872the Offeror after the Tender(Shareholding ratio after the Tender Offer
92.50%)

Offer
Numberofvoting

rightspertaining to the shares, etc.

0held by special related parties(Shareholding ratio after the Tender Offer
0.00%)

after the Tender Offer
Total number of voting rights
of all shareholders of the32,538Target(Note 1) "Number of voting rights pertaining to the shares held by special related parties before
the Tender Offer" and "Number of voting rights pertaining to the shares, etc. held byspecial related parties after the Tender Offer" are the total numbers of voting rights
pertaining to shares, etc. held by each special related party (excluding parties that shallbe excluded from special related parties pursuant to Article 3, Paragraph 2, Item (i) of theCabinet Office Ordinance for the purpose of calculating the shareholding ratio set out ineach item of Article 27-2, Paragraph 1 of the Act).
(Note 2) "Total number of voting rights of all shareholders of the Target" is the number of the voting
rights of all shareholders as of September 30, 2021 as indicated in the 2Q Securities Report.
However, because shares less than one unit and shares of Target's Stock that may be issued
or transferred as a result of exercise of the Stock Acquisition Rights are also subject to theTender Offer, "Shareholding ratio before the Tender Offer" and "Shareholding ratio after
the Tender Offer" are calculated based on the denominator of the number of voting rights(34,458) pertaining to the Total Number of Shares Adjusted for Dilutive Shares (3,445,876
shares).
(Note 3) "Shareholding ratio before the Tender Offer" and "Shareholding ratio after the Tender
Offer" are indicated by rounding to the second decimal place.
(5) Calculation in the case where the purchase is conducted on a pro-rata basis
Not applicable.

5(6) Method of settlement(I)

Name and location of head office of the financial instruments business operator or bank, etc. incharge of settlement of the tender offer(Tender offer agent)
SMBC Nikko Securities Inc.

3-1, Marunouchi 3-chome, Chiyoda-ku, Tokyo(II) Commencement date of settlement
January 6, 2022 (Thursday)(III) Method of settlement
A written notice concerning purchase, etc. through the Tender Offer shall be sent by post to theaddress or location of the tendering shareholders (or the standing proxy in the case of nonresident shareholders) without delay after completion of the Tender Offer Period. The notice shallbe given electronically for tenders made through Nikko Easy Trade.
The purchase shall be made in cash. The sales proceeds for the purchased shares, etc. shall beremitted from the tender offer agent to the location designated by the tendering shareholders (orthe standing proxy in the case of non-resident shareholders) without delay after thecommencement date of the settlement as instructed by the tendering shareholders (or the standing
proxy in the case of non-resident shareholders).

3. Policies after the Tender Offer and Perspectives
The Offeror Parties' policies after the Tender Offer have not been changed from those stated in the"Notice Regarding Commencement of Tender Offer for Shares of Human Associates Holdings, Inc.
(Securities Code: 6575)" published by the Offeror Parties on November 15, 2021.

4. Location at which copy of the Tender Offer Report is available to the public
MBK Wellness Holdings & CO., LTD.

2-1, Otemachi 1-chome, Chiyoda-ku, Tokyo

Tokyo Stock Exchange, Inc.

2-1, Nihombashi Kabuto-cho, Chuo-ku, TokyoEND

6